4,500-Patient study aims to predict heart and kidney risks
NCT ID NCT07327606
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will follow about 4,500 people with cardiovascular-kidney-metabolic (CKM) syndrome for at least 3 years. Researchers will collect blood samples and use stress echocardiograms to look for biomarkers that predict major heart problems like heart attack or stroke. The goal is to build a model that helps doctors tailor treatment and follow-up for each patient.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a predictive model that helps doctors personalize treatment and follow-up for people with cardiovascular-kidney-metabolic syndrome.
- What could go wrong
- This is an observational study, not a treatment trial. It may not find clear predictors, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PATIENT WITH CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking University Third Hospital
RECRUITINGBeijing, Beijing Municipality, 100191, China